European Journal of Nutrition

, Volume 48, Issue 3, pp 129–136

Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway

  • Kari Almendingen
  • Olau Fausa
  • Arne Tore Høstmark
  • Jorunn Bratlie
  • Lars Mørkerid
  • Lars Aabakken
  • Morten Harald Vatn
ORIGINAL CONTRIBUTION
  • 186 Downloads

Abstract

Background

Patients with familial adenomatous polyposis (FAP) are colectomized in young age in order to avoid development of colorectal cancer. Because colectomy radically changes gastrointestinal physiology, and food avoidance may be present, colectomized patients may be at risk for nutritional deficiency.

Aim of the study

to evaluate: (1) serum biochemical levels as compared to reference; (2) dietary intake as compared to the recommendations.

Methods

Blood samples, interviews and food frequency questionnaire were collected from 38 colectomized FAP patients with duodenal adenomas (mean age 40 years, range: 24–70). They were recruited from the Norwegian database on FAP.

Results

Serum albumin was significantly higher (P ≤ 0.0001), and Mg (P = 0.02), ferritin (P ≤ 0.001), and cholesterol (P = 0.03) significantly lower, than reference levels. Compared to recommendations, a low intake was seen for folate and fiber (<50%), iron, thiamin, riboflavin (<25%), and omega-3 fatty acids (8%). Sugar intake exceeded the recommendation, mainly due to a high intake of soft drinks. Food avoidance was reported by 53%.

Conclusions

We would suggest that the nutrient intake among FAP patients should at least meet the recommendations for healthy subjects. Their risk of metachronous cancers should also cause special attention to dietary factors that may prevent nutritional deficiency and carcinogenesis.

Keywords

familial adenomatous polyposis ileostomy colectomy diet nutritional status 

References

  1. 1.
    Almendingen K, Hostmark AT, Fausa O, Mosdol A, Aabakken L, Vatn MH (2007) Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids. Int J Cancer 120:632–637CrossRefGoogle Scholar
  2. 2.
    Andersen LF, Solvoll K, Johansson LR, Salminen I, Aro A, Drevon CA (1999) Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 150:75–87Google Scholar
  3. 3.
    Andersen LF, Veierod MB, Johansson L, Sakhi A, Solvoll K, Drevon CA (2005) Evaluation of three dietary assessment methods and serum biomarkers as measures of fruit and vegetable intake, using the method of triads. Br J Nutr 93:519–527CrossRefGoogle Scholar
  4. 4.
    Baisi A, Maruotti RA, Zannini P, Negri G, Voci C, Rebuffat C, Pietrojusti M (1987) Dietary management in patients with a colostomy. Panminerva Med 29:119–121Google Scholar
  5. 5.
    Baro L, Hermoso JC, Nunez MC, Jimenez-Rios JA, Gil A (1998) Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer 77:1978–1983Google Scholar
  6. 6.
    Becker W, Alexander J, Andersen S, Aro A, Fogelholm M, Lyhne N, Meltzer HM, Pedersen AN, Pedersen JI, Thorsdottir I (2006) Nordic nutrition recommendations. Ugeskr Laeger 168:76–77Google Scholar
  7. 7.
    Bingham S, Cummings JH, McNeil NI (1982) Diet and health of people with an ileostomy. 1: dietary assessment. Br J Nutr 47:399–406CrossRefGoogle Scholar
  8. 8.
    Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB (2008) Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 134:388–395CrossRefGoogle Scholar
  9. 9.
    Bras A, Sanches R, Cristovao L, Fidalgo P, Chagas C, Mexia J, Leitao N, Rueff J (1999) Oxidative stress in familial adenomatous polyposis. Eur J Cancer Prev 8:305–310CrossRefGoogle Scholar
  10. 10.
    Brevik A, Vollset SE, Tell GS, Refsum H, Ueland PM, Loeken EB, Drevon CA, Andersen LF (2005) Plasma concentration of folate as a biomarker for the intake of fruit and vegetables: the Hordaland Homocysteine study. Am J Clin Nutr 81:434–439Google Scholar
  11. 11.
    Bussey HJ, DeCosse JJ, Deschner EE, Eyers AA, Lesser ML, Morson BC, Ritchie SM, Thomson JP, Wadsworth J (1982) A randomized trial of ascorbic acid in polyposis coli. Cancer 50:1434–1439CrossRefGoogle Scholar
  12. 12.
    Christl SU, Scheppach W (1997) Metabolic consequences of total colectomy. Scand J Gastroenterol Suppl 222:20–24Google Scholar
  13. 13.
    Coffey JC, Winter DC, Neary P, Murphy A, Redmond HP, Kirwan WO (2002) Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the cleveland global quality of life instrument. Dis Colon Rectum 45:30–38Google Scholar
  14. 14.
    Corpet DE, Pierre F (2003) Point: from animal models to prevention of colon cancer systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 12:391–400Google Scholar
  15. 15.
    de Kok TM, van Breda SG, Manson MM (2008) Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 47(Suppl 2):51–59CrossRefGoogle Scholar
  16. 16.
    DeCosse JJ, Miller HH, Lesser ML (1989) Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst 81:1290–1297CrossRefGoogle Scholar
  17. 17.
    Ellegard L, Bosaeus I, Andersson H (2000) Will recommended changes in fat and fibre intake affect cholesterol absorption and sterol excretion? An ileostomy study. Eur J Clin Nutr 54:306–313CrossRefGoogle Scholar
  18. 18.
    Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, Boyle P (2008) Tobacco smoking and cancer: a meta-analysis. Int J Cancer 122:155–164CrossRefGoogle Scholar
  19. 19.
    Gazzard BG, Saunders B, Dawson AM (1978) Diets and stoma function. Br J Surg 65:642–644CrossRefGoogle Scholar
  20. 20.
    Johansson L, Solvoll L, Norkost K (1997) National dietary survey among men and women age 16–79 years 2/1999 (in Norwegian) 1999 Tha National Council on Nutrition and Physical Activity: Oslo. Ref Type: reportGoogle Scholar
  21. 21.
    Johansson L, Solvoll K, Bjorneboe GE, Drevon CA (1998) Under- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample. Am J Clin Nutr 68:266–274Google Scholar
  22. 22.
    Kim YI (2005) Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 135:2703–2709Google Scholar
  23. 23.
    Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661–665CrossRefGoogle Scholar
  24. 24.
    Kuisma J, Nuutinen H, Luukkonen P, Jarvinen H, Kahri A, Farkkila M (2001) Long term metabolic consequences of ileal pouch-anal anastomosis for ulcerative colitis. Am J Gastroenterol 96:3110–3116Google Scholar
  25. 25.
    M’koma AE (2006) Serum biochemical evaluation of patients with functional pouches 10–20 years after restorative proctocolectomy. Int J Colorectal Dis 21:711–720CrossRefGoogle Scholar
  26. 26.
    McNeil NI, Bingham S, Cole TJ, Grant AM, Cummings JH (1982) Diet and health of people with an ileostomy. 2: ileostomy function and nutritional state. Br J Nutr 47:407–415CrossRefGoogle Scholar
  27. 27.
    Nissinen MJ, Gylling H, Jarvinen HJ, Miettinen TA (2004) Ileal pouch-anal anastomosis, conventional ileostomy and ileorectal anastomosis modify cholesterol metabolism. Dig Dis Sci 49:1444–1453CrossRefGoogle Scholar
  28. 28.
    Okamoto T, Kusunoki M, Kusuhara K, Yamamura T, Utsunomiya J (1995) Water and electrolyte balance after ileal J pouch-anal anastomosis in ulcerative colitis and familial adenomatous polyposis. Int J Colorectal Dis 10:33–38CrossRefGoogle Scholar
  29. 29.
    Pironi L, Miglioli M, Ruggeri E, Dallasta MA, Poggioli G, Caudarella R, Piazzi S, Miniero R, Gozzetti G, Barbara L (1991) Nutritional status in patients undergoing ileal pouch-anal anastomosis. Clin Nutr 10:292–297CrossRefGoogle Scholar
  30. 30.
    Rustad P, Felding P, Lahti A, Hyltoft PP (2004) Descriptive analytical data and consequences for calculation of common reference intervals in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 64:343–370CrossRefGoogle Scholar
  31. 31.
    Spigelman AD, Uff CR, Phillips RK (1990) Vitamin C levels in patients with familial adenomatous polyposis. Br J Surg 77:508–509CrossRefGoogle Scholar
  32. 32.
    Thomson TJ, Runcie J, Khan A (1970) The effect of diet on ileostomy function. Gut 11:482–485CrossRefGoogle Scholar
  33. 33.
    Ulvik A, Evensen ET, Lien EA, Hoff G, Vollset SE, Majak BM, Ueland PM (2001) Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet 101:246–254CrossRefGoogle Scholar
  34. 34.
    Umhau JC, Dauphinais KM, Patel SH, Nahrwold DA, Hibbeln JR, Rawlings RR, George DT (2006) The relationship between folate and docosahexaenoic acid in men. Eur J Clin Nutr 60:352–357CrossRefGoogle Scholar
  35. 35.
    Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Jarvinen H, Mecklin JP, Moller P, Myrhoi T, Nagengast FM, Parc Y, Phillips R, Clark SK, de Leon MP, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713CrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2009

Authors and Affiliations

  • Kari Almendingen
    • 1
    • 2
  • Olau Fausa
    • 2
  • Arne Tore Høstmark
    • 3
  • Jorunn Bratlie
    • 2
  • Lars Mørkerid
    • 4
  • Lars Aabakken
    • 2
  • Morten Harald Vatn
    • 2
    • 5
  1. 1.Unit of Clinical Research, Research CenterAkershus University HospitalLørenskogNorway
  2. 2.Dept. of MedicineRikshospitalet University HospitalOsloNorway
  3. 3.Institute of General Practice and Community MedicineUniversity of OsloOsloNorway
  4. 4.Medical Center, Institute of Clinical BiochemistryUniversity of OsloOsloNorway
  5. 5.EpiGen, Faculty Division AkershusUniversity Hospital, University of OsloOsloNorway

Personalised recommendations